Compare F5 Inc (FFIV) vs GeneDx Holdings Corp (WGS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
F5 Inc vs GeneDx Holdings Corp — how do they compare? F5 Inc trades at $414 (market cap $23.44B), while GeneDx Holdings Corp trades at $82.5 (market cap $2.44B). The key difference: F5 Inc is far larger — about 9.6× GeneDx Holdings Corp's market cap, and F5 Inc is trading nearer its 52-week high, GeneDx Holdings Corp nearer its low. Which is the better fit depends on your goals.
| FFIV | WGS | |
|---|---|---|
Market Cap | $23.44B | $2.44B |
Sector | Technology | Technology |
52-Week High | $431.26 | $167.51 |
52-Week Low | $223.99 | $34.51 |
Enterprise Value | $22.08B | $2.48B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About F5 Inc
F5 is a market leader in the application delivery controller market. The company sells products for networking traffic, security, and policy management. Its products ensure applications are safely routed in efficient manners within on-premises data centers and across cloud environments. More than half of its revenue is based on providing services, and its three customer verticals are enterprises, service providers, and government entities. The Seattle-based firm was incorporated in 1996 and generates sales globally.
Read more on FFIV →About GeneDx Holdings Corp
GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.
Read more on WGS →
